Entera Bio Ltd (ENTX) — Cash Flow-to-Debt Ratio
Entera Bio Ltd (ENTX) has a Cash Flow-to-Debt Ratio of -1.26x as of September 2025, meaning its operating cash flow of $-2.74 Million could theoretically repay -1% of its total liabilities ($2.17 Million) in one year. Check Entera Bio Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Entera Bio Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Entera Bio Ltd across 10 annual periods. Also explore ENTX total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Entera Bio Ltd (2015–2024)
Year-by-year debt coverage analysis for Entera Bio Ltd. For market capitalisation and broader financial context, see ENTX market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.20x | $-6.82 Million | $1.31 Million | ▲ +1.8% |
| 2023 | -5.30x | $-7.31 Million | $1.38 Million | ▲ +41.8% |
| 2022 | -9.10x | $-12.50 Million | $1.37 Million | ▼ -243.7% |
| 2021 | -2.65x | $-9.06 Million | $3.42 Million | ▲ +44.5% |
| 2020 | -4.77x | $-10.56 Million | $2.21 Million | ▼ -156.0% |
| 2019 | -1.86x | $-8.92 Million | $4.78 Million | ▲ +38.6% |
| 2018 | -3.04x | $-9.80 Million | $3.23 Million | ▼ -2909.1% |
| 2017 | -0.10x | $-4.53 Million | $44.84 Million | ▼ -1.3% |
| 2016 | -0.10x | $-3.14 Million | $31.53 Million | ▲ +18.9% |
| 2015 | -0.12x | $-3.50 Million | $28.43 Million | — |